Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards

Burns. 2014 Mar;40(2):295-9. doi: 10.1016/j.burns.2013.06.003. Epub 2013 Jul 22.

Abstract

The study was conducted to investigate drug resistance, OXA-type carbapenemases-encoding genes and genetic diversity in airborne Acinetobacter baumannii (A. baumannii) in burn wards. Airborne A. baumannii were collected in burn wards and their corridors using Andersen 6-stage air sampler from January to June 2011. The isolates susceptibility to 13 commonly used antibiotics was examined according to the CLSI guidelines; OXA-type carbapenemases-encoding genes and molecular diversity of isolates were analyzed, respectively. A total of 16 non-repetitive A. baumannii were isolated, with 10 strains having a resistance rate of greater than 50% against the 13 antibiotics. The resistance rate against ceftriaxone, cyclophosvnamide, ciprofloxacin, and imipenem was 93.75% (15/16), but no isolate observed to be resistant to cefoperazone/sulbactam. Resistance gene analyses showed that all 16 isolates carried OXA-51, and 15 isolates carried OXA-23 except No.15; but OXA-24 and OXA-58 resistance genes not detected. The isolates were classified into 13 genotypes (A-M) according to repetitive extragenic palindromic sequence PCR (REP-PCR) results and only six isolates had a homology ≥90%. In conclusion, airborne A. baumannii in the burn wards had multidrug resistance and complex molecular diversity, and OXA-23 and OXA-51 were dominant mechanisms for resisting carbapenems.

Keywords: Airborne Acinetobacter baumannii; Burn wards; Molecular diversity; OXA-type carbapenemases-encoding resistance genes; REP-PCR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter baumannii / drug effects
  • Acinetobacter baumannii / genetics*
  • Acinetobacter baumannii / isolation & purification
  • Air Microbiology*
  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics
  • Burn Units*
  • Carbapenems / pharmacology*
  • Cefoperazone / pharmacology
  • Ceftriaxone / pharmacology
  • Ciprofloxacin / pharmacology
  • DNA, Bacterial / genetics*
  • Drug Resistance, Multiple, Bacterial / genetics
  • Humans
  • Imipenem / pharmacology
  • Microbial Sensitivity Tests
  • Polymerase Chain Reaction
  • Repetitive Sequences, Nucleic Acid
  • Sulbactam / pharmacology
  • beta-Lactamases / genetics*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Carbapenems
  • DNA, Bacterial
  • Ciprofloxacin
  • Imipenem
  • Ceftriaxone
  • Cefoperazone
  • beta-lactamase OXA-23
  • beta-Lactamases
  • beta-lactamase OXA-24
  • beta-lactamase OXA-51, Acinetobacter baumannii
  • beta-lactamase OXA-58, Acinetobacter baumannii
  • Sulbactam